tiprankstipranks
Trending News
More News >
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ:AVIR
US Market

Atea Pharmaceuticals (AVIR) Cash flow

Compare
234 Followers

Atea Pharmaceuticals Cash Flow

AVIR's free cash flow for Q3 2025 was $-40.38M. For the 2025 fiscal year, AVIR's free cash flow was decreased by $-50.10M and operating cash flow was $-40.38M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -135.50M$ -85.39M$ -120.98M$ -87.00M$ 296.73M
Investing Cash Flow
$ 56.10M$ 40.30M$ -455.41M$ -4.00K$ -26.00K
Financing Cash Flow
$ 267.00K$ 257.00K$ 370.00K$ 1.47M$ 531.75M
End Cash Position
$ 64.70M$ 143.82M$ 188.66M$ 764.68M$ 850.22M
Free Cash Flow
$ -135.50M$ -85.39M$ -122.92M$ -87.01M$ 296.71M
Currency in USD

Atea Pharmaceuticals Cash Flow